ArticleDrug delivery2022

GRP78-targeted and doxorubicin-loaded nanodroplets combined with ultrasound: a potential novel theranostics for castration-resistant prostate cancer.

Yading Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.